{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:23Z","timestamp":1791357263891,"version":"4.3.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T00:00:00Z","timestamp":1473897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T00:00:00Z","timestamp":1473897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2016,9,15]]},"DOI":"10.5664\/jcsm.6116","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T15:00:34Z","timestamp":1473865234000},"page":"1215-1225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials"],"prefix":"10.1007","volume":"12","author":[{"given":"W. Joseph","family":"Herring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane B.","family":"Snavely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Hutzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Matzura-Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Benca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Krystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"key":"1209004_CR1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L de Lecea","year":"1998","unstructured":"de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamusspecific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998;95:322\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1209004_CR2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573\u201385.","journal-title":"Cell"},{"key":"1209004_CR3","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1021\/jm100541c","volume":"53","author":"CD Cox","year":"2010","unstructured":"Cox CD, Breslin MJ, Whitman DB, et al. Discovery of the dual orexin receptor antagonist[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia. J Med Chem 2010;53:5320\u201332.","journal-title":"J Med Chem"},{"key":"1209004_CR4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/01677063.2011.566953","volume":"25","author":"CJ Winrow","year":"2011","unstructured":"Winrow CJ, Gotter AL, Cox CD, et al. Promotion of sleep by MK-4305 - a novel dual orexin receptor antagonist. J Neurogenetics 2011;25:52\u201361.","journal-title":"J Neurogenetics"},{"key":"1209004_CR5","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","volume":"79","author":"WJ Herring","year":"2012","unstructured":"Herring WJ, Snyder E, Budd K, et al. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology 2012;79:2265\u201374.","journal-title":"Neurology"},{"key":"1209004_CR6","first-page":"259","volume":"36","author":"H Sun","year":"2013","unstructured":"Sun H, Kennedy WP, Wilbraham D, et al. Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men. Sleep 2013;36:259\u201367.","journal-title":"Sleep"},{"key":"1209004_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(14)70053-5","volume":"13","author":"D Michelson","year":"2014","unstructured":"Michelson D, Snyder E, Paradis E, et al. Safety and efficacy of suvorexant, an orexin receptor antagonist, during 1-year treatment of insomnia followed by abrupt discontinuation of treatment: a randomized, double-blind, placebo-controlled clinical trial. Lancet Neurol 2014;13:461\u201371.","journal-title":"Lancet Neurol"},{"key":"1209004_CR8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biopsych.2014.10.003","volume":"79","author":"WJ Herring","year":"2016","unstructured":"Herring WJ, Connor KM, Ivgy-May N, et al. Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials. Biol Psychiatry 2016;79:136\u201348.","journal-title":"Biol Psychiatry"},{"key":"1209004_CR9","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","volume":"18","author":"C Peyron","year":"1998","unstructured":"Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996\u201310015.","journal-title":"J Neurosci"},{"key":"1209004_CR10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","volume":"98","author":"RM Chemelli","year":"1999","unstructured":"Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437\u201351.","journal-title":"Cell"},{"key":"1209004_CR11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","volume":"98","author":"L Lin","year":"1999","unstructured":"Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365\u201376.","journal-title":"Cell"},{"key":"1209004_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","volume":"355","author":"S Nishino","year":"2000","unstructured":"Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39\u201340.","journal-title":"Lancet"},{"key":"1209004_CR13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","volume":"6","author":"C Peyron","year":"2000","unstructured":"Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991\u20137.","journal-title":"Nat Med"},{"key":"1209004_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3940(99)00955-6","volume":"279","author":"S Taheri","year":"2000","unstructured":"Taheri S, Sunter D, Dakin C, et al. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neurosci Lett 2000;279:109\u201312.","journal-title":"Neurosci Lett"},{"key":"1209004_CR15","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1523\/JNEUROSCI.23-08-03555.2003","volume":"23","author":"JM Zeitzer","year":"2003","unstructured":"Zeitzer JM, Buckmaster CL, Parker KJ, Hauck CM, Lyons DM, Mignot E. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci 2003;23:3555\u201360.","journal-title":"J Neurosci"},{"key":"1209004_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40263-012-0036-8","volume":"27","author":"M Mieda","year":"2013","unstructured":"Mieda M, Sakurai T. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status. CNS Drugs 2013;27:83\u201390.","journal-title":"CNS Drugs"},{"key":"1209004_CR17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s13311-012-0148-3","volume":"9","author":"T Roehrs","year":"2012","unstructured":"Roehrs T, Roth T. Insomnia pharmacotherapy. Neurotherapeutics 2012;9:728\u201338.","journal-title":"Neurotherapeutics"},{"key":"1209004_CR18","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., Text Revision. Washington, D.C.: American Psychiatric Association, 2000.","edition":"4"},{"key":"1209004_CR19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","volume":"2","author":"CH Bastien","year":"2001","unstructured":"Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297\u2013307.","journal-title":"Sleep Med"},{"key":"1209004_CR20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","volume":"168","author":"K Posner","year":"2011","unstructured":"Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 2011;168:1266\u201377.","journal-title":"Am J Psychiatry"},{"key":"1209004_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-0327(90)90009-W","volume":"19","author":"P Tyrer","year":"1990","unstructured":"Tyrer P, Murphy S, Riley P. The benzodiazepine withdrawal symptom questionnaire. J Affect Disord 1990;19:53\u20136.","journal-title":"J Affect Disord"},{"key":"1209004_CR22","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1185\/03007990903167415","volume":"25","author":"M Yang","year":"2009","unstructured":"Yang M, Morin CM, Schaefer K, Wallenstein GV. Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference. Curr Med Res Opin 2009;25:2487\u201394.","journal-title":"Curr Med Res Opin"},{"key":"1209004_CR23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.sleep.2006.04.008","volume":"7","author":"T Roth","year":"2006","unstructured":"Roth T, Soubrane C, Titeux L, Walsh JK. Zoladult Study Group Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia. Sleep Med 2006;7:397\u2013406.","journal-title":"Sleep Med"},{"key":"1209004_CR24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrneurol.2015.99","volume":"11","author":"L Shan","year":"2015","unstructured":"Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol 2015;11:401\u201313.","journal-title":"Nat Rev Neurol"},{"key":"1209004_CR25","doi-asserted-by":"crossref","unstructured":"Vermeeren A, Vets E, Vuurman EF, et al. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly. Psychopharmacology (Berl). 2016 Jul 16. [Epub ahead of print].","DOI":"10.1007\/s00213-016-4375-x"},{"key":"1209004_CR26","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.5665\/sleep.5168","volume":"38","author":"A Vermeeren","year":"2015","unstructured":"Vermeeren A, Sun H, Vuurman EF, et al. On-the-road driving performance the morning after bedtime use of suvorexant 20 and 40 mg: a study in non-elderly healthy volunteers. Sleep 2015;38:1803\u201313.","journal-title":"Sleep"},{"key":"1209004_CR27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1474-4422(14)70218-2","volume":"14","author":"RS Liblau","year":"2015","unstructured":"Liblau RS, Vassalli A, Seifinejad A, Tafti M. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol 2015;14:318\u201328.","journal-title":"Lancet Neurol"},{"key":"1209004_CR28","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1212\/WNL.52.6.1194","volume":"52","author":"MM Ohayon","year":"1999","unstructured":"Ohayon MM, Zulley J, Guilleminault C, Smirne S. Prevalence and pathologic associations of sleep paralysis in the general population. Neurology 1999;52:1194\u2013200.","journal-title":"Neurology"},{"key":"1209004_CR29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-1781(00)00227-4","volume":"97","author":"MM Ohayon","year":"2000","unstructured":"Ohayon MM. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 2000;97:153\u201364.","journal-title":"Psychiatry Res"},{"key":"1209004_CR30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00002826-200001000-00011","volume":"23","author":"LC Toner","year":"2000","unstructured":"Toner LC, Tsambiras BM, Catalano G, Catalano MC, Cooper DS. Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol 2000;23:54\u20138.","journal-title":"Clin Neuropharmacol"},{"key":"1209004_CR31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00228-008-0494-6","volume":"64","author":"Y Zopf","year":"2008","unstructured":"Zopf Y, Rabe C, Neubert A, et al. Women encounter ADRs more often than do men. Eur J Clin Pharmacol 2008;64:999\u20131004.","journal-title":"Eur J Clin Pharmacol"},{"key":"1209004_CR32","doi-asserted-by":"crossref","first-page":"e8343","DOI":"10.1136\/bmj.e8343","volume":"345","author":"TB Huedo-Medina","year":"2012","unstructured":"Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ 2012;345:e8343.","journal-title":"BMJ"},{"key":"1209004_CR33","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.2174\/13816128113196660695","volume":"20","author":"A Corsonello","year":"2014","unstructured":"Corsonello A, Onder G, Maggio M, Corica F, Lattanzio F. Medications affecting functional status in older persons. Curr Pharm Des 2014;20:3256\u201363.","journal-title":"Curr Pharm Des"},{"key":"1209004_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/17512433.2014.864949","volume":"7","author":"HB Levy","year":"2014","unstructured":"Levy HB. Non-benzodiazepine hypnotics and older adults: what are we learning about zolpidem? Expert Rev Clin Pharmacol 2014;7:5\u20138.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1209004_CR35","first-page":"225","volume":"162","author":"AM Holbrook","year":"2000","unstructured":"Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000;162:225\u201333.","journal-title":"CMAJ"},{"key":"1209004_CR36","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11606-007-0251-z","volume":"22","author":"N Buscemi","year":"2007","unstructured":"Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007;22:1335\u201350.","journal-title":"J Gen Intern Med"},{"key":"1209004_CR37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","volume":"4","author":"OS Miettinen","year":"1985","unstructured":"Miettinen OS, Nurminen M. Comparative analysis of two rates. Stat Med 1985;4:213\u2013226.","journal-title":"Stat Med"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.6116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.6116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.aasmnet.org\/jcsm\/viewabstract.aspx?pid=30777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.6116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:15:56Z","timestamp":1770365756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.5664\/jcsm.6116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9,15]]}},"alternative-id":["1209004"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.6116","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]},"assertion":[{"value":"1 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}